CALL/FRESENIUS/50/0.1/21.06.24 Share Price

Warrant

DE000GQ21XV2

Market Closed - BOERSE MUENCHEN 11:57:19 31/05/2024 pm IST
0.001 EUR -.--% Intraday chart for CALL/FRESENIUS/50/0.1/21.06.24
Date Price Change
31/24/31 0.001 -.--%
30/24/30 0.001 -.--%
29/24/29 0.001 -.--%
28/24/28 0.001 -.--%
27/24/27 0.001 -.--%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 11:57 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Goldman Sachs
WKN GQ21XV
ISINDE000GQ21XV2
Date issued 11/08/2023
Strike 50
Maturity 21/06/2024 (21 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.017
Lowest since issue 0.001
Spread 0.03
Spread %96.77%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.28 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.43%
Consensus